Illustration: Camille MacMillin/STAT; Photos: Adobe

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01.

Finding the right treatment for someone with Crohn’s disease or ulcerative colitis is more of an art than a science.

The chronic autoimmune conditions — both considered types of inflammatory bowel disease — cause a myriad of symptoms including ulcers, stomach cramps, fatigue, and diarrhea. Some patients have all of these symptoms, while others have just one or two. They all trace back to chronic inflammation in the digestive tract.

Advertisement

There are treatment options. Several of the drugs that have landed on pharmacy shelves over the last two decades can be used to address the various overactive parts of the immune system that wreak havoc on the gut. But pairing patients with a medication takes guesswork, and across the board, only about 30% of people with inflammatory bowel disease, or IBD, find relief. 

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe